Inventor
Wolfgang Froestl
Inventor
Ecublens, CH
Overview
Patents· 11 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes28%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations28%
C07DHeterocyclic compounds25%
G01NInvestigating or analysing materials by determining their chemical or physical properties10%
C07CAcyclic or carbocyclic compounds8%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium3%
PatentTitleYear
10,662,193Carbazole and carboline compounds for use in the diagnosis, treatment, alleviation or prevention of disorders associated with amyloid or amyloid-like proteins202010,500,207Compounds for the treatment of diseases associated with amyloid or amyloid-like proteins20199,701,660'2,6-diaminopyridine compounds suitable for treating diseases associated with amyloid or amyloid-like proteins or for treating or preventing ocular diseases or conditions associated with a pathological abnormality/change in the tissue of the visual system'20179,221,812'Compounds for the treatment of diseases associated with amyloid or amyloid-like proteins'20158,916,590'2,6-diaminopyridine compounds suitable for treating diseases associated with amyloid or amyloid-like proteins or for treating or preventing ocular diseases or conditions associated with a pathological abnormality/change in the tissue of the visual system'20148,673,940'Compounds for the treatment of diseases associated with amyloid or amyloid-like proteins'20148,513,268'1H-quinazoline-2,4-diones processes for their production, pharmaceutical compositions, and treatment for epilepsy'20138,299,085'Quinazoline derivatives'20128,012,988'N-(2,4-dioxo-6-(tetrahydrofuran-2-yl)-7-(trifluoromethyl)-1,4-dihydro-2H-quinazolin-3-yl)methanesulfonamide'20117,655,666'Substituted 1H-quinazoline-2,4-diones useful as AMPA receptor ligands'20107,498,319'Phosphinic acid derivatives'2009Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2009–2013Patents assigned to NOVARTIS AG (5)· patent assignee history
2009–2019Based in Ecublens, CH· patent location history
2010Based in Basel, CH· patent location history
2012–2015Patents assigned to FROESTL WOLFGANG (5)· patent assignee history
2012–2013Patents assigned to ALLGEIER HANS (2)· patent assignee history
2014–2020Patents assigned to AC IMMUNE SA (6)· patent assignee history
2014–2015Patents assigned to MUHS ANDREAS (3)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| AC IMMUNE SA | 6 | 2014–2020 |
| FROESTL WOLFGANGself | 5 | 2012–2015 |
| NOVARTIS AG | 5 | 2009–2013 |
| MUHS ANDREAS | 3 | 2014–2015 |
| ALLGEIER HANS | 2 | 2012–2013 |
Locations
| Location | Patents | Span |
|---|---|---|
| Ecublens, CH | 9 | 2009–2019 |
| — | 1 | 2020 |
| Basel, CH | 1 | 2010 |